Latest Headlines

Latest Headlines

Quintiles deepens its Latin American ties with Argentine partnership

Quintiles is further entrenching itself in Latin America, striking a deep-rooted alliance with a research site in Buenos Aires to widen its global network of trusted partners.

Quintiles and Quest team up for lab testing with $575M JV

Months after LabCorp acquired its rival Covance, Quintiles has signed a sweeping agreement with lab testing giant Quest Diagnostics to launch a joint venture focused on clinical trials.

Quest and Quintiles team up for JV aimed at clinical research, diagnostics

Quest Diagnostics is forming a joint venture with global CRO Quintiles to provide laboratory services for clinical trials, lending its research and diagnostic know-how to biopharma partners with precision medicine initiatives.

Quintiles, Quest create JV to offer clinical trial lab services, companion diagnostics

Quest Diagnostics is partnering with contract research organization Quintiles to create a joint venture to provide a range of clinical trial services to biopharmas including laboratory testing and patient recruitment and retention as well as development and commercialization of companion diagnostics.

Quintiles taps Google partner Tute Genomics for R&D

Quintiles, the world's largest CRO, has reached out to startup Tute Genomics for access to its database of 8.5 billion annotations of genetic variants.

Quintiles shedding 270 jobs in a cost-cutting move

Global CRO Quintiles is planning to lay off about 270 workers, 1% of its payroll, in an effort to reduce "excess capacity," the company said.

Quintiles looks to 2015 with another banner year in the books

After clearing roughly $4.2 billion in revenue in 2014, Quintiles is projecting another big year ahead, as the world's largest CRO counts on its backlog to keep business rolling in.

Quintiles' founder heads for the exit after 30-plus years as chairman

Quintiles founder Dennis Gillings is planning to step down from his role as chairman by the end of the year, endorsing the leadership of CEO Tom Pike and transitioning into a more advisory role at the world's largest CRO.

Quintiles pools postmarketing services into a single offering

Quintiles has unveiled a new offering that combines its pharmacovigilance, label management, risk-benefit research and analytics into a single product, touting the service as a catch-all for approved drugs.

Data registries: An extremely powerful tool, at least in theory

Data-gathering tools face a number of challenges including the integration of UDIs, differing device systems and components, and obtaining sufficient follow-up information, and capturing differences in provider experiences and training that could skew the outcomes data.